Corpus StriatumChronic DiseaseSubstantia NigraMultiple SclerosisDopamine3,4-Dihydroxyphenylacetic AcidBrainReceptors, DopamineAcute DiseaseMagnetic Resonance ImagingBerberineCorpus LuteumCorpus CallosumOxidopamineMPTP PoisoningParkinson Disease, SecondaryRats, Inbred Strains1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeuronsRats, Sprague-DawleyTyrosine 3-MonooxygenaseNeostriatumParkinsonian DisordersAgenesis of Corpus CallosumParkinson DiseaseDopamine Plasma Membrane Transport ProteinsDopaminergic NeuronsPutamenHomovanillic AcidBasal GangliaApomorphineCaudate NucleusDopamine AgentsMedial Forebrain BundleLevodopaNeural PathwaysReceptors, Dopamine D2Nerve DegenerationMotor ActivityMesencephalonDopamine AgonistsSaimiriBehavior, AnimalAdrenergic AgentsDisease Models, AnimalHydroxydopaminesAmphetamineDopamine AntagonistsTetrabenazineGlial Cell Line-Derived Neurotrophic Factoralpha-SynucleinDihydroxyphenylalanineStriatonigral DegenerationCorpora AllataTropanesSympatholyticsStereotyped BehaviorConotoxins1-Methyl-4-phenylpyridiniumAntiparkinson AgentsMice, Inbred C57BLFetal Tissue TransplantationCocaineBrain Tissue TransplantationRacloprideDyskinesia, Drug-InducedReceptors, Dopamine D1ImmunohistochemistryMicrodialysisAutoradiographyNerve Tissue ProteinsNeurotoxinsDopamine Uptake InhibitorsVesicular Monoamine Transport ProteinsPenisHaloperidolNeuroprotective AgentsHypokinesiaNomifensineQuinpiroleCorpus Luteum MaintenanceMethamphetamineAnalysis of VarianceGlobus PallidusTime FactorsNucleus AccumbensLuteolysisBenserazideRats, WistarManebProgesterone